SCHEMBL6921052

SCHEMBL6921052

Oc1cccc2c1c1cccc(F)c1n2Cc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GAA P10253 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.40
PLA2G2A P14555 2/20 0.39
FABP4 P15090 2/20 0.39
POLB P06746 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924122 0.90 PLA2G2A (0.46) MEN1KMT2ATP53ALDH1A1MAPT
SCHEMBL6924605 0.88 MEN1 (0.43) MEN1KMT2ATSHRTP53ALDH1A1
SCHEMBL6926616 0.87 LMNA (0.44) MEN1KMT2ATSHRTP53ALDH1A1
SCHEMBL6921048 0.80 HDAC1 (0.43) MEN1KMT2ATSHRTP53ALDH1A1
SCHEMBL6926577 0.76 MAPT (0.43) MEN1KMT2ATSHRALDH1A1MAPT
SCHEMBL6923683 0.75 KDM4E (0.44) MEN1KMT2ATP53ALDH1A1MAPT
SCHEMBL6926546 0.75 CYP19A1 (0.47) MEN1KMT2ATP53ALDH1A1MAPT
SCHEMBL6927392 0.74 ATM (0.53) MEN1KMT2AALDH1A1MAPTNPSR1
SCHEMBL6921487 0.74 ESR1 (0.43) MEN1KMT2ATSHRTP53ALDH1A1
SCHEMBL6923669 0.73 SRC (0.50) MEN1KMT2AALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed